Publications

Procyrion Aortix℠

ALL
Press Releases
Articles
Publications
Awards

Procyrion Honored As An Innovator Reshaping Texas

Texas Monthly

Procyrion recognized in Texas Monthly Magazine as on of the 15 Innovators Reshaping Texas.

January 29, 2018
  • Articles
  • Publications

Giving the Heart a Rest

TMC News

A new medical device is poised to help heart failure patients without invasive surgery

September 6, 2017
  • Articles

Preliminary Data Published in American Society for Artificial Internal Organs Journal

ASAIO

Published in ASAIO's May 2013 issue, Procyrion's journal article, "Improved hemodynamics with a novel miniaturized intra-aortic axial flow pump in a porcine model of acute left ventricular dysfunction".

May 15, 2013
  • Publications
The Aortix™ device is currently in the research and development phase and is not available for sale in any country.
Caution: Investigational Device. Limited by Federal Law to Investigational Use.

Links

HomeClinical TrialsOverviewTeamNewsCareersReferencesDisclaimer & Terms of UseContact

LATEST NEWS

March 2024
Fierce Biotech
Procyrion Recognized in Fierce Medtech's Fierce15 of 2023
February 2024
Press Release
Procyrion Closes $57.7 Million in Series E Financing
November 2023
Press Release
Procyrion Announces First Patient Enrollments in the DRAIN-HF Pivotal IDE Trial for Aortix™ Percutaneous Mechanical Circulatory Support Technology

ABOUT US

Procyrion is a team of experienced life science entrepreneurs, engineers, cardiologists, and heart failure specialists.

Our dedicated team is working to address the unmet clinical needs of heart failure patients through the development of a safe and innovative percutaneous mechanical circulatory support (pMCS) device.

Copyright © 2021 Procyrion, Inc.
Disclaimer & Terms of Use
Aortix™ is for investigational use only and is not for sale in the United States.